{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:03:22Z","timestamp":1781186602300,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T00:00:00Z","timestamp":1380758400000},"content-version":"vor","delay-in-days":397,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100003085","name":"Longer Life Foundation","doi-asserted-by":"publisher","award":["HL085124"],"award-info":[{"award-number":["HL085124"]}],"id":[{"id":"10.13039\/100003085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003085","name":"Longer Life Foundation","doi-asserted-by":"publisher","award":["HL103871"],"award-info":[{"award-number":["HL103871"]}],"id":[{"id":"10.13039\/100003085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR013396"],"award-info":[{"award-number":["NR013396"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 HL077113"],"award-info":[{"award-number":["P50 HL077113"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jacc.2012.02.051","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T17:15:24Z","timestamp":1339607724000},"page":"898-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Adrenergic-Pathway Gene Variants Influence Beta-Blocker\u2013Related Outcomes After Acute Coronary Syndrome in a Race-Specific Manner"],"prefix":"10.1016","volume":"60","author":[{"given":"Sharon","family":"Cresci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Gerald W.","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L.","family":"Beitelshees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allie Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra A.","family":"Lenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Province","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Lanfear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2012.02.051_bib1","first-page":"e46","article-title":"Heart disease and stroke statistics\u20142010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.02.051_bib2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction","volume":"36","author":"Braunwald","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacc.2007.10.001","article-title":"2007 focused update of the ACC\/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"51","author":"Antman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib4","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2008.10.012","volume":"52","author":"Krumholz","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.02.051_bib6","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2012.02.051_bib7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.amjcard.2004.05.069","article-title":"Association of race with complications and prognosis following acute coronary syndromes","volume":"94","author":"Asher","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib8","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.02.051_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.02.051_bib10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.02.051_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1054\/jcaf.2000.17610","article-title":"Heart failure in African Americans: a cardiovascular engima","volume":"6","author":"Yancy","year":"2000","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2012.02.051_bib12","doi-asserted-by":"crossref","first-page":"3i","DOI":"10.1016\/j.amjcard.2005.07.028","article-title":"Heart failure in African Americans","volume":"96","author":"Yancy","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.05.009","article-title":"Clinical and genetic modifiers of long-term survival in heart failure","volume":"54","author":"Cresci","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib14","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1073\/pnas.0509937103","article-title":"A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure","volume":"103","author":"Liggett","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2012.02.051_bib15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nm1750","article-title":"A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure","volume":"14","author":"Liggett","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2012.02.051_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","article-title":"Beta-adrenergic receptor blockade in chronic heart failure","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.02.051_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjcard.2006.08.020","article-title":"Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure","volume":"99","author":"Shin","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCHEARTFAILURE.109.885962","article-title":"An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure","volume":"3","author":"Bristow","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2012.02.051_bib19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.294.12.1526","article-title":"Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome","volume":"294","author":"Lanfear","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.02.051_bib20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.jacc.2005.05.092","article-title":"The influence of race on health status outcomes one year after an acute coronary syndrome","volume":"46","author":"Spertus","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/jama.297.14.1551","article-title":"Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study","volume":"297","author":"Morgan","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.02.051_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ahj.2005.05.026","article-title":"The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)\u2014evaluating the impact of myocardial infarction on patient outcomes","volume":"151","author":"Spertus","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.02.051_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.02.051_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/gm255","article-title":"Factors influencing patient willingness to participate in genetic research after a myocardial infarction","volume":"3","author":"Lanfear","year":"2011","journal-title":"Genome Med"},{"key":"10.1016\/j.jacc.2012.02.051_bib25","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers","volume":"132","author":"Rozen","year":"2000","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jacc.2012.02.051_bib26","first-page":"97","article-title":"Pyrosequencing of clinically relevant polymorphisms","volume":"311","author":"Marsh","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jacc.2012.02.051_bib27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/339368","article-title":"Ethnic-difference markers for use in mapping by admixture linkage disequilibrium","volume":"70","author":"Collins-Schramm","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2012.02.051_bib28","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.111.029173","article-title":"Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial","volume":"124","author":"Cresci","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.02.051_bib29","series-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"2003"},{"key":"10.1016\/j.jacc.2012.02.051_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/14622416.5.5.553","article-title":"Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure","volume":"5","author":"Lanfear","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jacc.2012.02.051_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jacc.2005.10.020","volume":"47","author":"Krumholz","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jacc.2005.03.011","article-title":"American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care","volume":"45","author":"Spertus","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib34","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(01)01702-8","article-title":"American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes","volume":"38","author":"Cannon","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMoa020803","article-title":"Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure","volume":"347","author":"Small","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.02.051_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nuclcard.2003.07.001","article-title":"Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic alpha2C-adrenergic receptor","volume":"10","author":"Gerson","year":"2003","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jacc.2012.02.051_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/FPC.0b013e3280105245","article-title":"Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure","volume":"17","author":"Lobmeyer","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jacc.2012.02.051_bib38","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/01.CIR.0000141297.50027.A4","article-title":"Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial","volume":"110","author":"Bristow","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.02.051_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/mol.63.1.9","article-title":"Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization","volume":"63","author":"Kohout","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jacc.2012.02.051_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9149(00)01354-0","article-title":"Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality","volume":"87","author":"Muhlestein","year":"2001","journal-title":"Am J Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712013964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712013964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:37:00Z","timestamp":1778546220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712013964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0735109712013964"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2012.02.051","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenergic-Pathway Gene Variants Influence Beta-Blocker\u2013Related Outcomes After Acute Coronary Syndrome in a Race-Specific Manner","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2012.02.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}